ORG Wealth Partners
PRCT icon

ORG Wealth Partners’s Procept Biorobotics PRCT Stock Holding History

ORG Wealth Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$528 Buy
+29
New +$578 ﹤0.01% 2023

Other funds holding PRCT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

ORG Wealth Partners's PRCT Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Procept Biorobotics (PRCT) in Q3 2026: 29 shares worth $528. The stake represents ﹤0.01% of the portfolio and ranks #2023 among its holdings.

171 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • ORG Wealth Partners held 29 shares of Procept Biorobotics worth $528 as of Q3 2026.
  • Procept Biorobotics was a new ORG Wealth Partners position in Q3 2026.
  • Procept Biorobotics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2023 holding.
  • 171 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.